source
- Anthony Fauci’s pandemic-era diary entriesNew data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds
- Apnimed eyes up to $160M IPO to prep for sleep apnea drug launchIf the offering closes, Apnimed will join the 2026 IPO class that has already far surpassed last year’s total.